These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36409180)

  • 1. Muscle plasticity is influenced by renal function and caloric intake through the FGF23-vitamin D axis.
    Acevedo LM; Vidal Á; Aguilera-Tejero E; Rivero JL
    Am J Physiol Cell Physiol; 2023 Jan; 324(1):C14-C28. PubMed ID: 36409180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.
    Quarles LD
    Exp Cell Res; 2012 May; 318(9):1040-8. PubMed ID: 22421513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System.
    Latic N; Erben RG
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PTH-Vitamin D-FGF23 axis.
    Blau JE; Collins MT
    Rev Endocr Metab Disord; 2015 Jun; 16(2):165-74. PubMed ID: 26296372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
    Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis.
    Martin A; Quarles LD
    Adv Exp Med Biol; 2012; 728():65-83. PubMed ID: 22396162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
    Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
    Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
    Gutiérrez OM
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D and Phosphate Interactions in Health and Disease.
    Akimbekov NS; Digel I; Sherelkhan DK; Razzaque MS
    Adv Exp Med Biol; 2022; 1362():37-46. PubMed ID: 35288871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression.
    Meyer MB; Pike JW
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105500. PubMed ID: 31629064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FGF23, a "new" hormone regulating phosphate homeostasis and vitamin D metabolism].
    Silve C
    Presse Med; 2005 Nov; 34(19 Pt 1):1384-90. PubMed ID: 16292192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caloric Intake in Renal Patients: Repercussions on Mineral Metabolism.
    Vidal A; Ríos R; Pineda C; López I; Raya AI; Aguilera-Tejero E; Rodríguez M
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S; Gupta A; Quarles LD
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3.
    Kägi L; Bettoni C; Pastor-Arroyo EM; Schnitzbauer U; Hernando N; Wagner CA
    PLoS One; 2018; 13(5):e0195427. PubMed ID: 29771914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of hormone-sensitive renal phosphate transport.
    Gattineni J; Friedman PA
    Vitam Horm; 2015; 98():249-306. PubMed ID: 25817872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
    Komaba H
    Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of FGF23 under physiological and pathophysiological conditions.
    Rausch S; Föller M
    Pflugers Arch; 2022 Mar; 474(3):281-292. PubMed ID: 35084563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
    Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
    J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.